CN Patent

CN1921840A — 多层片剂

Assigned to Boehringer Ingelheim International GmbH · Expires 2007-02-28 · 19y expired

What this patent protects

本发明涉及多层片剂，其包含配制成用于血管紧张素Ⅱ受体拮抗剂替米沙坦自溶解性片剂基质即时释放的第一层、配制成用于血管紧张素转化酶抑制剂雷米普剂以及任选地利尿剂自崩解性片剂基质即时释放的第二层，以及任选地配制成用于利尿剂如氢氯噻嗪自快速崩解性片剂基质即时释放的第三层。

USPTO Abstract

本发明涉及多层片剂，其包含配制成用于血管紧张素Ⅱ受体拮抗剂替米沙坦自溶解性片剂基质即时释放的第一层、配制成用于血管紧张素转化酶抑制剂雷米普剂以及任选地利尿剂自崩解性片剂基质即时释放的第二层，以及任选地配制成用于利尿剂如氢氯噻嗪自快速崩解性片剂基质即时释放的第三层。

Drugs covered by this patent

Patent Metadata

Patent number
CN1921840A
Jurisdiction
CN
Classification
—
Expires
2007-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.